Early detection of steatohepatitis in fatty rat liver by using MR elastography

Radiology

Volumn 253, Issue 1, 2009, Pages 90-97

  Salameh, Najat ^a   Larrat, Benoît ^b   Abarca Quinones, Jorge ^a   Pallu, Stéphane ^a   Dorvillius, Mylène ^a   Leclercq, Isabelle ^a   Fink, Mathias ^b   Sinkus, Ralph ^b   Van Beerse, Bernard E ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b INSTITUT LANGEVIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHOLINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; OROTIC ACID; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1; CARBON TETRACHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; ELASTOGRAPHY; FATTY LIVER; FIBROGENESIS; HISTOLOGY; IMAGING SYSTEM; INFLAMMATION; LIVER; MAGNETIC RESONANCE ELASTOGRAPHY; MORPHOMETRICS; MYOFIBROBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; VISCOELASTICITY; ANIMAL; MALE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VITAMIN DEFICIENCY;

ANIMALS; CARBON TETRACHLORIDE; CHOLINE DEFICIENCY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; MALE; OROTIC ACID; PROCOLLAGEN; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70350516182     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2523081817     Document Type: Article

References (39)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43(2 suppl 1):S99-S112.
2. Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB (Oxford) 2007;9(2):92-97.
3. Nobili V, Manco M, Devito R, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008;48(1):119-128.
4. Sagi R, Reif S, Neuman G, Webb M, Phillip M, Shalitin S. Nonalcoholic fatty liver disease in overweight children and adolescents. Acta Paediatr 2007;96(8):1209-1213.
5. Imhof A, Kratzer W, Boehm B, et al. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. Eur J Epidemiol 2007;22(12):889-897.
6. Oh MK, Winn J, Poordad F. Review article: diagnosis and treatment of non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008;28(5):503-522.
7. Siebler J, Galle PR. Treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2006;12(14):2161-2167.
8. Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007;46(2):582-589.
9. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237(3):1048-1055.
10. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques - initial experience. Radiology 2005;237(2):507-511.
11. Reeder SB, McKenzie CA, Pineda AR, et al. Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging 2007;25(3):644-652.
12. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006;19(2):173-179.
13. Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 2007;245(2):458-466.
14. Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 2008;135(1):32-40.
15. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary results. Radiology 2006;240(2):440-448.
16. Salameh N, Peeters F, Sinkus R, et al. Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 2007;26(4):956-962.
17. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007;5(10):1207-1213.
18. Yin M, Woollard J, Wang X, et al. Quantitative assessment of hepatic fibrosis in an animal model with magnetic resonance elastography. Magn Reson Med 2007;58(2):346-353.
19. Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41(1):48-54.
20. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29(12):1705-1713.
21. Coco B, Oliveri F, Maina AM, et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14(5):360-369.
22. Lupsor M, Badea R, Stefanescu H, et al. Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C: results from a cohort of 324 patients. J Gastrointestin Liver Dis 2008;17(2):155-163.
23. Yoneda M, Fujita K, Inamori M, Tamano M, Hiriishi H, Nakajima A. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007;56(9):1330-1331.
24. Yoneda M, Mawatari H, Fujita K, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40(5):371-378.
25. Georges PC, Hui JJ, Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 2007;293(6):G1147-G1154.
26. Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47(2):380-384.
27. Ibanez P, Solis N, Pizarro M, et al. Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2007;22(6):846-851.
28. Leclercq IA, Sempoux C, Starkel P, Horsmans Y. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats. Gut 2006;55(7):1020-1029.
29. Starkel P, Sempoux C, Leclercq I, et al. Oxidative stress, KLF6 and transforming growth factor-β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003;39(4):538-546.
30. Sinkus R, Tanter M, Catheline S, et al. Imaging anisotropic and viscous properties of breast tissue by magnetic resonance-elastography. Magn Reson Med 2005;53(2):372-387.
31. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227(3):617-622.
32. Norman GR, Streiner DL. Biostatistics: the base essentials. Toronto, Canada: Decker, 2000.
33. Gaca MD, Zhou X, Issa R, Kiriella K, Iredale JP, Benyon RC. Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol 2003;22(3):229-239.
34. Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblast. Wound Repair Regen 2005;13(1):7-12.
35. Wells RG. The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J Clin Gastroenterol 2005;39(4 suppl 2):S158-S161.
36. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechanoregulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002;3(5):349-363.
37. Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117(3):539-548.
38. McCuskey RS, Ito Y, Robertson GR, McCuskey MK, Perry M, Farrell GC. Hepatic microvascular dysfunction during evolution of dietary steatohepatitis in mice. Hepatology 2004;40(2):386-393.
39. Nakae D. Endogenous liver carcinogenesis in the rat. Pathol Int 1999;49(12):1028-1042.